Patents by Inventor Yonggang LIAO

Yonggang LIAO has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • DIMETHYLSULFOXIMINE DERIVATIVE
    Publication number: 20230219920
    Abstract: Disclosed in the present invention is a series of dimethylsulfoximine derivatives, and specifically disclosed are a compound represented by formula (II) and a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: June 7, 2021
    Publication date: July 13, 2023
    Inventors: Wenyuan QIAN, Yonggang LIAO, Changqing WEI, Zhengying XI, Yao XIAO, Shuhui CHEN
  • Diazaindole derivative and use thereof as CHK1 inhibitor
    Patent number: 11634424
    Abstract: Disclosed are a diazaindole derivative as shown in formula I and the use thereof in the preparation of a drug for treating Chk1-related diseases.
    Type: Grant
    Filed: November 27, 2020
    Date of Patent: April 25, 2023
    Assignee: MEDSHINE DISCOVERY INC.
    Inventors: Yonggang Liao, Wenyuan Qian, Changqing Wei, Yao Xiao, Zhengying Xi, Chen Zhang, Jian Li, Shuhui Chen
  • DIAZAINDOLE DERIVATIVE AND USE THEREOF AS CHK1 INHIBITOR
    Publication number: 20230017858
    Abstract: Disclosed are a diazaindole derivative as shown in formula I and the use thereof in the preparation of a drug for treating Chk1-related diseases.
    Type: Application
    Filed: November 27, 2020
    Publication date: January 19, 2023
    Inventors: Yonggang LIAO, Wenyuan QIAN, Changqing WEI, Yao XIAO, Zhengying XI, Chen ZHANG, Jian LI, Shuhui CHEN
  • Compound as GLS1 inhibitor
    Patent number: 11254666
    Abstract: A compound as a GLS1 inhibitor as represented by formula (I) or a pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: June 13, 2018
    Date of Patent: February 22, 2022
    Assignee: MEDSHINE DISCOVERY INC.
    Inventors: Yonggang Liao, Chaonan Liu, Changqing Wei, Hao Wu, Shuhui Chen
  • Substituted 1,3,4-thiadiazoles as GLS1 inhibitors
    Patent number: 11230544
    Abstract: Disclosed is to a thiadiazole derivative and the uses thereof in preparing a drug for treating GLS1-associated diseases. Specifically disclosed is a derivative compound of formula (I), a tautomer thereof or a pharmaceutically acceptable composition thereof.
    Type: Grant
    Filed: October 15, 2019
    Date of Patent: January 25, 2022
    Assignee: MEDSHINE DISCOVERY INC.
    Inventors: Yonggang Liao, Jun Lin, Chaonan Liu, Changqing Wei, Wenyuan Qian, Chen Zhang, Zhen Gong, Jian Li, Shuhui Chen
  • Crystal forms and salt forms of 7h-pyrrolo[2,3-d]pyrimidine compounds and preparation method thereof
    Patent number: 10774094
    Abstract: The present invention discloses crystal forms and salt forms of a 7H-pyrrolo[2,3-d]pyrimidine compounds and preparation methods thereof, and further discloses use of the crystal forms and the salt forms in the manufacture of a medicament for treating arthritis.
    Type: Grant
    Filed: November 23, 2017
    Date of Patent: September 15, 2020
    Assignee: Wuxi Fortune Pharmaceutical Co., Ltd
    Inventors: Weiwei Mao, Hao Wu, Qiang Guo, Xuejian Zheng, Yonggang Liao
  • HDAC6 selective inhibitors, preparation method therefor, and application thereof
    Patent number: 10745389
    Abstract: Compounds serving as histone deacetylase 6 (HDAC6) selective inhibitors, and applications thereof in the preparation of drugs for treating HDAC6-related diseases. Specifically disclosed are a compound as represented by formula (I) and a pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: January 10, 2018
    Date of Patent: August 18, 2020
    Assignees: CSTONE PHARMACEUTICALS (SUZHOU) CO., LTD., CSTONE PHARMACEUTICALS (SHANGHAI) CO., LTD, CSTONE PHARMACEUTICALS
    Inventors: Hao Wu, Changqing Wei, Qiang Guo, Guifen Zhang, Bin Liu, Yonggang Liao, Yao Xiao, Shuhui Chen
  • COMPOUND AS GLS1 INHIBITOR
    Publication number: 20200216436
    Abstract: A compound as a GLS1 inhibitor as represented by formula (I) or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: June 13, 2018
    Publication date: July 9, 2020
    Inventors: Yonggang LIAO, Chaonan LIU, Changqing WEI, Hao WU, Shuhui CHEN
  • HDAC6 Selective Inhibitors, Preparation Method Therefor, and Application Thereof
    Publication number: 20190375735
    Abstract: Compounds serving as histone deacetylase 6 (HDAC6) selective inhibitors, and applications thereof in the preparation of drugs for treating HDAC6-related diseases. Specifically disclosed are a compound as represented by formula (I) and a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: January 10, 2018
    Publication date: December 12, 2019
    Inventors: Hao Wu, Changqing Wei, Qiang Guo, Guifen Zhang, Bin Liu, Yonggang Liao, Yao Xiao, Shuhui Chen
  • Crystal Forms And Salt Forms Of 7h-Pyrrolo[2,3-D]Pyrimidine Compounds And Preparation Method Thereof
    Publication number: 20190218231
    Abstract: The present invention discloses crystal forms and salt forms of a 7H-pyrrolo[2,3-d]pyrimidine compounds and preparation methods thereof, and further discloses use of the crystal forms and the salt forms in the manufacture of a medicament for treating arthritis.
    Type: Application
    Filed: November 23, 2017
    Publication date: July 18, 2019
    Inventors: Weiwei MAO, Hao WU, Qiang GUO, Xuejian ZHENG, Yonggang LIAO